Delayed recovery of myocardial perfusion in acute myocardial infarction: A scintigraphic study after early thrombolytic treatment

Coronary Artery Disease

Volumn 9, Issue 7, 1998, Pages 443-449

  Bouvier, Frederic ^a   Höjer, Jonas ^a   Samad, Bassem A ^a   Jensen Urstad, Kerstin ^a   Ruiz, Hernan ^a   Hulting, Johan ^a   Jensen Urstad, Mats ^b  

^a STOCKHOLM SÖDER HOSPITAL   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Adenosine stress test; Infarct size; MIBI SPECT; Myocardial viability; Thrombolytically treated myocardial infarction

Indexed keywords

ADENOSINE; FIBRINOLYTIC AGENT;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; CONTROLLED STUDY; FEMALE; HEART MUSCLE; HEART MUSCLE PERFUSION; HEART SCINTISCANNING; HUMAN; MAJOR CLINICAL STUDY; MALE; PHARMACOLOGIC STRESS TESTING; PRIORITY JOURNAL; RISK ASSESSMENT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 0031729947     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019501-199809070-00007     Document Type: Article

References (33)

1. Gimple LW, Beller GA. Assessing prognosis after myocardial infarction in the thrombolytic era. J Nucl Cardiol 1994; 1:198-209.
2. Toft E, Nielson G, Mortensen B, Aaroe J, Dalsgaard D, Hansen JB. The prognostic value of exercise testing early after myocardial infarction in patients treated with thrombolytics. Eur Heart J 1995; 16: 1177-1180.
3. Stevenson R, Umachadran V, Ranjadalayan K, Wilkinson P, Marchant B, Timmis AD. Reassessment of treadmill stress testing for risk stratification in patients with acute myocardial infarction treated by thrombolysis. Br Heart J 1993, 70:415-420.
4. Marx BE, Bertel A, Amman FW. Late recurrent ischemia in infarct patients with a normal predischarge exercise test after thrombolysis. Eur Heart J 1990; 11:897-902.
5. Zaret LB, Wackers FJ. Nuclear cardiology [review]. N Engl J Med 1993; 329:775-783.
6. Brown KA, O'Meara J, Chambers CE, Plante DA. Ability of dipyridamole-thallium-201 imaging 1-4 days after myocardial infarction to predict in-hospital and late recurrent myocardial ischemic events. Am J Cardiol 1990; 65:160-167.
7. Mahmarian JJ, Pratt CM, Nishimura S, Abreu A, Verani MS. Quantitative adenosine thallium-201 SPECT for the early assessment of patients surviving acute myocardial infarction. Circulation 1993; 87: 1197-1210.
8. Nienaber CA, Spielmann RP, Salge D, Montz R, Bleifeld W. Assessment of post-infarction jeopardized myocardium by vasodilatation-thallium-201 tomography: impact on risk stratification. Eur Heart J 1990; 11:1093-1100.
9. Travin MI, Dessouki A, Cameron T, Heler GV. Use of exercise technetium-99m sestamibi SPECT imaging to detect residual ischemia and for risk stratification after acute myocardial infarction. Am J Cardiol 1995; 75:665-669.
10. Zaret LB, Beller GA. Nuclear cardiology. St Louis, Missouri: Mosby-Year Book, Inc; 1992. pp. 170-179.
11. Zaret LB, Beller GA. Nuclear cardiology. St Louis, Missouri: Mosby-Year Book, Inc., 1991. pp. 29-30, 53-55, 78-81, 210.
12. Crane P, Laliberte R, Heminway S, Thoolen M, Orlandi C. Effect of mitochondrial viability and metabolism on technetium-99m-sestamibi myocardial infarction. Eur J Nucl Med 1993; 20:20-25.
13. Dilsizian V, Arrighi JA, Diodati JG, Quyyumi AA, Alavi K, Bacharach SL. Myocardial viability in patients with chronic coronary artery disease, comparison of 99m Tc-sestamibi with thallium reinjection and F-18 fluorodeoxyglucose. Circulation 1994; 89:578-587.
14. Keyes JW, Leonard PF, Brody SL, Svetkoff DJ, Rogers WL, Lucchesi BR. Myocardial infarct quantification in the dog by single photon emission tomography. Circulation 1978; 58:227-232.
15. Verani MS, Jeroudi MO, Mahmarian JJ, Boyce TM, Borges-Neto S, Patel B. Quantification of myocardial infarction during coronary occlusion and myocardial salvage after reperfusion using cardiac imaging with technetium-99m hexakis 2-methoxyisobutyl isonrtrile. J Am Coll Cardiol 1988; 12:1573-1581.
16. Sinusas AJ, Watson DD, Cannon JM, Beller GA. Effect of ischemia and postischemic dysfunction on myocardial uptake of technetium 99m-labeled methoxyisobutyl isonitrile and thallium-201. J Am Coll Cardiol 1989; 14:1785-1793.
17. O'Connor MK, Hammel T, Gibbson RL. In vitro validation of a simple tomographic technique for estimation of percentage myocardium at risk using methoxyisobutyl isonitrile technetium 99m (sestamibi). Eur J Nucl Med 1990; 17:69-76.
18. Udelson JE, Coleman PS, Metheral J, Pandian NG, Gomez AR, Griffith JL. Predicting recovery of severe regional ventricular dysfunction. Comparison of resting scintigraphy with 201 T1 and 99m Tc-sestamibi. Circulation 1994; 89:2552-2561.
19. Gibbons RJ, Verani MS, Behrenbeck T, Pelikka PA, O'Connor MK, Mahmarian JJ. Feasibility of tomographic 99mTc-hexakis-2-methoxy-2-methylpropyl-isonitrile imaging for the assessment of myocardial area at risk and the effect of treatment in acute myocardial infarction. Circulation 1989; 80:1277-1286.
20. Christian TF, Behrenbeck T, Gersh BJ, Gibbons RJ. Relation of left ventricular volume and function over one year after acute myocardial infarction to infarct size determined by technetium-99m sestamibi. Am J Cardiol 1991; 68:21-26.
21. Chareonthaitawee P, Christian TF, Hirose K, Gibbons RJ, Rumberger JA. Relation of initial infarct size to extent of left ventricular remodeling in the year after myocardial infarction. J Am Coll Cardiol 1995; 25:567-573.
22. Verani MS, Jeroudi MO, Mahmarian JJ, Boyce TM, Borges-Neto S, Patel B. Quantification of myocardial infarction during coronary occlusion and myocardial salvage after reperfusion using cardiac imaging with technetium 99m hexakis 2-methoxyisobutyl isonitrile. J Am Coll Cardiol 1988; 12:1573-1581.
23. Galli M, Marcassa C, Bolli R, Gianuzzi P, Temporelli PL, Imparato A. Spontaneous delayed recovery of perfusion and contraction after the first 5 weeks after anterior infarction. Circulation 1994; 90:1386-1397.
24. Dilsizian V, Arrighi JA, Diodati JG, Quyyumi AA, Bacharach SL, Marin-Neto JA. Myocardial viability in patients with chronic ischemic left ventricular dysfunction: comparison of Tc-99m sestamibi, thallium-201 and F-18 fluorodeoxyglucose. Circulation 1994; 89:578-587.
25. Brunken R, Schwaiger M, Grover-McCay M, Phelps ME, Tillisch J, Schelbert HR. Positron emission tomography detects tissue metabolic activity in myocardial segments with persistent thallium perfusion defects. J Am Coll Cardiol 1987; 10:557-567.
26. Udelson JE. Can technetium 99m-labeled sestamibi track myocardial viability? J Nucl Cardiol 1995; 1:571-575.
27. Henes CG, Bergmann SR, Perez JE, Sobel BE, Geltman EM. The time course of restoration of nutritive perfusion, myocardial oxygen consumption, and regional function after coronary thrombolysis. Coron Artery Dis 1990; 1:687-696.
28. Leon AR, Eisner RL, Martin SE, Schmarkey LS, Aaron AM, Boyers AS. Comparison of single photon emission computed tomographic (SPECT) myocardial perfusion imaging with thallium-201 and technetium 99m sestamibi in dogs. J Am Coll Cardiol 1992; 20:1612-1625.
29. Bonow RO. The hibernating myocardium: implications for management of congestive heart failure. Am J Cardiol 1995; 75:17A-25A.
30. Bax JJ, Visser FC, Van Lingen A, Huitink JM, Kamp O, van Leeuwen GW. Feasibility of assessing regional myocardial uptake of F-18-fluorodeoxyglucose using single photon emission computed tomography. Eur Heart J 1993; 14:1675-1682.
31. Iskandrian AS, Schelbert HR. Myocardial viability assessment [overview]. J Nucl Med 1994; 34 (suppl):1S-3S.
32. Smart SC, Sawada S, Ryan T, Segar D, Atherton L, Berkowits K, et al. Low-dose dobutamine echocardiography detects reversible dysfunction after thrombolytic therapy of acute myocardial infarction. Circulation 1993; 88:405-415.
33. Mahmarian JJ, Mahmarian AC, Marks GF, Pratt GM, Verani MS. Role of adenosine thallium-201 tomography for defining long-term risk patients after myocardial infarction. J Am Coll Cardiol 1995; 25:1330-1340.